First Page | Document Content | |
---|---|---|
![]() Date: 2013-09-30 13:12:42Biotechnology Veltuzumab Milatuzumab Labetuzumab Systemic lupus erythematosus Yttrium (90Y) clivatuzumab tetraxetan Humanized antibody Epratuzumab Tolerx Monoclonal antibodies Anatomy Medicine | Add to Reading List |
![]() | Visterra to Present Data at ICAAC on VIS513, its Humanized Monoclonal Antibody That Targets a Conserved Site on the Dengue Virus E Protein ‒ VIS513 engineered to bind and potently neutralize all four serotypes of denguDocID: 1v1w4 - View Document |
![]() | Metadata Specifications: Antibodies Custom Fields Common FieldsDocID: 1pqfc - View Document |
![]() | Importance Antibodies LINCS Field Name 1: RequiredDocID: 1pbqh - View Document |
![]() | THE UNIVERSITY OF NEW MEXICO COLLEGE OF PHARMACY ALBUQUERQUE, NEW MEXICO ?DocID: 1p32j - View Document |
![]() | Poster LFB AACR bis:Mise en page:09 Page1 Towards a new targeted therapy for ovarian cancer: development of an anti-human müllerian inhibiting substance type II receptor humanized antibody Alexandra JacquDocID: 1d8zz - View Document |